AIFF logo

FIREFLY NEUROSCIENCE INC

AIFFNASDAQ
🏆 #4683 by market capUS Equity
$1.03▲ $0.02 (+1.49%)
Pre-market · at close
🔔
Track AIFF
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 1.5%
7d▲ 1.0%
14d▼ 6.8%
30d▼ 36.5%
ytd▲ 19.2%
1y▼ 46.6%
🏦Market Cap
$16M
Small Cap
📈Revenue Growth (YoY)
320.3%
High Growth
📊Gross Margin
44.6%
Healthy
💵FCF Margin
58.4%
Strong
⚖️P/S Ratio
8.7x
Elevated
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$1.02 – $1.02
52-Week Range
$0.62 – $3.15
Volume (shares)
337
Avg Volume (shares)
—
Shares Outstanding
15.7M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$1M
Last Q Revenue
$514,000
P/E Ratio
—
P/S Ratio
8.7x
EPS (TTM)
$-0.60
Dividend Yield
—
Dilution (1yr)
+61.3%
AIFF logo

FIREFLY NEUROSCIENCE INC

AIFF
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1M▲ +957.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
56.5%▲ +48.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$9M▼ −6.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$8M▲ +26.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
13.5M▲ +61.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▲ +$2M YoY
StockOtter · stockotter.space

About FIREFLY NEUROSCIENCE INC

Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.